Composite quality measure (CQM) attainment in overweight/obese patients with type 2 diabetes mellitus treated with canagliflozin 300 mg (CANA) or sitagliptin 100 mg (SITA)
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1397
https://www.valueinhealthjournal.com/article/S1098-3015(14)01448-X/fulltext
Title :
Composite quality measure (CQM) attainment in overweight/obese patients with type 2 diabetes mellitus treated with canagliflozin 300 mg (CANA) or sitagliptin 100 mg (SITA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01448-X&doi=10.1016/j.jval.2014.03.1397
First page :
A239
Section Title :
Diabetes/Endocrine Disorders I
Open access? :
No
Section Order :
863